New injection could slash morphine use after spinal fusion

NCT ID NCT04904575

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tests whether a numbing injection called an erector spinae plane block can lower the amount of morphine patients need after lumbar spinal fusion surgery. Researchers will compare morphine use over 72 hours in 130 adults receiving either the block or a placebo. The goal is to improve pain control while reducing opioid-related side effects.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

erector spinae plane block (a numbing injection near the spine)

What this could lead to

If it works, this could offer a way to reduce opioid painkiller use after back surgery, leading to fewer side effects and faster recovery.

What could go wrong

This is a relatively small, single-center trial. The block may not significantly reduce morphine use, and there are always risks like infection or nerve damage from the injection.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for LUMBAR SPINAL FUSION are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Clinique Saint Jean

    RECRUITING

    Saint-Jean-de-Védas, 34430, France

    Contact

    Contact

    Contact Phone: •••-•••-•••• Email: •••••@•••••